SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001628280-23-034696
Filing Date
2023-10-19
Accepted
2023-10-19 16:15:07
Documents
1
Period of Report
2022-12-31
Effectiveness Date
2023-10-19

Document Format Files

Seq Description Document Type Size
1 ARS avtx10-k2022_arsfiling1.pdf ARS 1610184
  Complete submission text file 0001628280-23-034696.txt   2217632
Mailing Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850
Business Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850 410-522-8707
Avalo Therapeutics, Inc. (Filer) CIK: 0001534120 (see all company filings)

IRS No.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-37590 | Film No.: 231334875
SIC: 2834 Pharmaceutical Preparations